Voltarol Science Academy

Introduction to Voltarol Science Academy

Voltarol is committed to being the world’s leading body pain expert. We understand that pain isn’t just physical discomfort – it’s a barrier to freedom, to sociability, to self-reliance – all the things that make up the joy of movement.

When choosing the most appropriate treatment for a patient, there are a number of factors to consider. This page has been developed to share a series of resources which can support you and your team when dealing with patients with musculoskeletal (MSK) pain in pharmacy.

Resources here include:

  • Bite size videos on the formulation and mode of action of topical pain relief including Voltarol
  • A flow chart and print/video resources on the management of joint pain in pharmacy, aligned to NICE guidance
  • Resources from the ‘Listen to Pain’ series designed to support patient consultations on pain
The science of Voltarol

Not all topical diclofenac products are the same.

Voltarol is the only clinically proven 2.32% diclofenac gel to demonstrate deep tissue penetration into joints.

  • Formulated with oleyl alcohol, a permeation enhancer – proven to deliver up to 3x greater skin penetration
  • Effective delivery of diclofenac through the skin
  • Strikes at the site of pain and inflammation
  • Up to 12 hours long lasting pain relief for sprains, strains, back pain, joint pain and now osteoarthritis

Voltarol Science Academy videos

Voltarol brand introduction

Voltarol brand introduction

David Urqhart, Senior Director R & D at Haleon provides an introduction to the Voltarol brand for the management of musculoskeletal pain.

Watch now

Formulation matters for topical pain relief

Formulation matters for topical pain relief

This video provides an insight into the assessment of topical pain relief formulations based on potency, penetration, pain on movement reduction and suitability. Learn more about the unique permeation enhancer in Voltarol.

Watch now

The burden of pain and patient impacts

The burden of pain and patient impacts

As well as the physiological burden, pain also impacts on emotional wellbeing and quality of life. Learn more about the patient impacts of pain.

Watch now

Patient case studies

Patient case studies

This video provides insight into the lives of two patients with musculoskeletal pain and explains how Voltarol Gel can help.

Watch now

Voltarol brand history

Voltarol brand history

Since 1974, the Voltarol brand has helped millions of patients keep hold of the things that matter to them. Learn more about the brand history.

Watch now

An introduction to MSK pain and the Voltarol range

An introduction to MSK pain and the Voltarol range

When part of your body is injured or damaged, pain-causing molecules called prostaglandins are produced with the help of COX-2 enzymes. NSAIDs relieve pain by blocking these enzymes, preventing them from producing pain-causing molecules.

This video details how the Voltarol Range can offer relief from musculoskeletal pain.

Watch now

Product details

  • Voltarol Product Information

    Product Information: Voltarol Max Strength Pain Relief 2.32% Gel (diclofenac diethylammonium). Indications Local symptomatic relief of pain and inflammation in trauma of the tendons, ligaments, muscles and joints e.g. due to sprains, strains and bruises and localised forms of soft tissue rheumatism. Relief of pain of non-serious arthritic conditions. Dosage and method of use Adults and children aged 14 years and over. Gently rub 2-4 g into skin of affected site. Apply 2 times daily (morning and evening) for up to 14 days. Maximum daily dose 8 g. If symptoms worsen or do not improve within 7 days, seek medical advice. Not for use for longer than 14 days unless recommended by doctor. Contraindications Patients whose asthma, angioedema, urticaria or acute rhinitis are precipitated by aspirin or other NSAIDs. Hypersensitivity to diclofenac, aspirin, other NSAIDs or excipients. Third trimester of pregnancy. Precautions Do not use on large areas of skin and over a prolonged period. Apply only to intact, non-diseased skin. Do not use with occlusion. Avoid ingestion or contact with eyes or mucous membranes. Caution in patients with previous or active peptic ulceration; suffering from/previous history of asthma or allergic disease. Discontinue use if skin rash develops. Caution with concomitant use of other diclofenac products or systemic NSAIDs. Contains propylene glycol and butylhydroxytoluene which may cause skin irritation. Do not smoke and avoid naked flames. Avoid excessive exposure to sunlight to avoid photosensitivity. Side effects See SPCs for full details. Rash, erythema, pruritus, dermatitis, eczema. Hypersensitivity (including urticaria), angioedema. Asthma. Photosensitivity reactions. Desquamation, skin discolouration. Product licence number, legal category, pack size and RSP (excl. VAT) PL 44673/0154 (P), 30 g £7.08, 50 g £9.99, 100 g £16.24. PL holder Haleon UK Trading Limited, The Heights, Weybridge, KT13 0NY, U.K. Date of revision May 2023.

Learn More

patient resources icon

Patient care resources

Access patient care resources.

Learn more

resources icon

Educational Resources

Access videos and interactive content for pharmacy on the management of patients with musculoskeletal pain.

Access now

webinar icon

Pain Relief Webinars

Access our webinar series.

Watch now